Sputnik V effective against new coronavirus strains, Vaccines journal says

Sputnik V effective against new coronavirus strains, Vaccines journal says

0 0
Read Time:2 Minute, 15 Second

According to the statement, Sputnik V demonstrated significantly less of a reduction in its virus-neutralizing activity against a number of variants compared to data from other vaccine producers

MOSCOW, RUSSIA – JULY 8, 2021: A medical worker prepares a syringe with the Sputnik Light one-component vaccine at a COVID-19 vaccination center opened at the Luzhniki sports complex. Having the capacity of 15,000 patients per day, the Luzhniki COVID-19 vaccination center is one of the largest in the world. Anton Novoderezhkin/TASS

MOSCOW, July 12. /TASS/. The Sputnik V vaccine is effective against new coronavirus strains according to the study results by the Gamaleya National Research Center for Epidemiology and Microbiology published in the Vaccines leading international journal, the Russian Direct Investment Fund (RDIF) reported on Monday.

“The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced strong results of the study on neutralizing activity of sera from individuals vaccinated with Sputnik V vaccine against new variants of SARS-CoV-2. Vaccination with Sputnik V has produced protective neutralizing titers against new variants, including Alpha B.1.1.7 (first identified in UK), Beta B.1.351 (first identified in South Africa), Gamma P.1 (first identified in Brazil), Delta B.1.617.2 and B.1.617.3 (first identified in India) and Moscow endemic variants B.1.1.141 and B.1.1.317 with mutations in the receptor-binding domain (RBD),” the statement said.

It is noted that the data shows that Sputnik V retains its protective properties against the new strains. “Notably, Sputnik V demonstrated significantly less of a reduction in its virus neutralizing activity against a number of variants compared to data from other vaccine producers, which had earlier confirmed the efficacy of their vaccines against new variants of coronavirus,” the statement noted.

The RDIF also reported that the Gamaleya Center had been actively studying the new SARS-CoV-2 strains in order to evaluate the efficacy of the Sputnik V vaccine as they continue to emerge in various parts of the world. The Center and the Foundation are also considering opportunities to develop “vaccine cocktails” jointly with other leading producers using the first component of the Sputnik V shot.

To date, Sputnik V has been registered in 67 countries with a total population surpassing 3.5 bln people. Data from the regulators of a number of countries, including Mexico, Argentina, Serbia, Bahrain, Hungary, San Marino, the UAE and others, obtained during the inoculation of residents, demonstrates that Sputnik V is one of the safest and most effective vaccines against the coronavirus infection.

Source: Tass News Agency

About Post Author

The Radical Outlook

The Radical Outlook is an online news web Portal designed for in-depth news analysis from the Eurasian region and beyond. It is Founded by a geopolitical analyst Shahzada Rahim.
Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Optimized with PageSpeed Ninja